StemCells, Inc. to Participate at the 17th Annual BIO CEO & Investor Conference
February 02, 2015 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Feb. 2, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Management will make a presentation on the Company's programs and operations at the 17th Annual BIO...
Stem Cells Inc. Posts Letter to Shareholders
January 26, 2015 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Jan. 26, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system,...
StemCells, Inc. Transplants First Participant in Phase II Clinical Trial in Cervical Spinal Cord Injury
December 18, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of disorders of the central...
StemCells, Inc. Hosts Leading Biotech Investors and Analysts at Inaugural Event
December 02, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Dec. 2, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leader in the development of cell-based therapies for disorders of the central nervous system (CNS), hosted its first...
StemCells, Inc. to Host Inaugural Investor and Analyst Event in New York
November 20, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Nov. 20, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), who pioneered the discovery and development of HuCNS-SC® cells, a proprietary population of highly purified,...
StemCells, Inc. Reports Third Quarter 2014 Financial and Operating Results
November 05, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Nov. 5, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), which pioneered the discovery and development of HuCNS-SC® cells, a proprietary population of highly purified,...
StemCells, Inc. to Host Inaugural Investor and Analyst Event in New York
November 03, 2014 17:25 ET
|
StemCells, Inc.
NEWARK, Calif., Nov. 3, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), who pioneered the discovery and development of HuCNS-SC® cells, a proprietary population of highly purified,...
StemCells, Inc. Initiates Phase II Clinical Trial in Cervical Spinal Cord Injury
October 07, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Oct. 7, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a world leader in the research and development of cell based therapies for the treatment of disorders of the central...
StemCells, Inc. to Participate at the 2014 Stem Cell Meeting on the Mesa
October 01, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Oct. 1, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will make a presentation on the Company's programs and operations...
StemCells, Inc. to Participate at the 16th Annual Rodman & Renshaw Global Investment Conference
September 04, 2014 16:05 ET
|
StemCells, Inc.
NEWARK, Calif., Sept. 4, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will present at the 16th Annual Rodman & Renshaw Global Investment Conference...